The Effect of Anatomy-based Fitting on the Perception of Speech in Noise and Music in Single-sided Deaf Cochlear Implant Users

July 17, 2026 updated by: University Hospital, Antwerp
The present study evaluates the effect of anatomy-based fitting on speech perception in noise and music perception in newly implanted single-sided deaf (SSD) CI recipients. Speech perception in noise will be assessed using different spatial configurations of speech and noise. Music perception will be evaluated using objective measurements for melody, harmony, timbre and pitch and using a subjective questionnaire, the Music and Cochlear implant questionnaire (MCIQ). Furthermore, localization and self-reported hearing benefit (HISQUI19, SSQ12) will be assessed.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antwerp, Belgium, 2650
        • Recruiting
        • Antwerp University Hopsital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Post-lingual onset of unilateral severe-to-profound sensorineural hearing loss
  • Contralateral hearing < 30 dB HL (PTA measured at 500Hz, 1kHz, 2kHz en 4 kHz)
  • Post-operative Computed Tomography (CT) scan of the CI elec-trode available
  • Subject implanted with MED-EL cochlear implant(s)
  • Subjects received a Flex20, Flex24, Flex28, FlexSoft, Flex34 or Standard electrode
  • Subject planned to receive a SONNET 2, SONNET 3 or RONDO 3 audio processor on the newly implanted side
  • Newly implanted CI users
  • The most apical active electrode contact has to be inserted at least 540°
  • Minimum of 10 active channels can be activated
  • Fluent in the language of the test centre
  • Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure

Exclusion Criteria:

  • Lack of compliance with any inclusion criteria
  • Implanted with C40+, C40X and C40C
  • Implanted with an ABI or Split electrode array
  • Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Anatomy-based fitting
Anatomy-based programming of the speech processor of the cochlear implant
Anatomy-based programming of the speech processor of the cochlear implant
Active Comparator: Default fitting
Default programming of the speech processor of the cochlear implant according to standard clinical practice
Default programming of the speech processor of the cochlear implant according to standard clinical practice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speech perception in noise
Time Frame: 3 months post-activation of the audioprocessor
Speech reception threshold in dB SNR for the following spatial configurations: S0N0, S0NSSD and SSSDNNH, measured with and without the cochlear implant
3 months post-activation of the audioprocessor
Speech perception in noise
Time Frame: 6 months post-activation of the audioprocessor
Speech reception threshold in dB SNR for the following spatial configurations: S0N0, S0NSSD and SSSDNNH, measured with and without the cochlear implant
6 months post-activation of the audioprocessor
Speech perception in noise
Time Frame: 12 months post-activation of the audioprocessor
Speech reception threshold in dB SNR for the following spatial configurations: S0N0, S0NSSD and SSSDNNH, measured with and without the cochlear implant
12 months post-activation of the audioprocessor

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pitch ranking
Time Frame: 3 months post-activation
Frequency difference in semitones between CI and NH
3 months post-activation
Pitch ranking
Time Frame: 6 months post-activation
Frequency difference in semitones between CI and NH
6 months post-activation
Pitch ranking
Time Frame: 12 months post-activation
Frequency difference in semitones between CI and NH
12 months post-activation
Perception of timbre
Time Frame: 3 months post-activation
Score on Visual Analog Scale (VAS). Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, with a score of 5 indicating a similar timbre between CI and NH.
3 months post-activation
Perception of timbre
Time Frame: 6 months post-activation
Score on Visual Analog Scale (VAS). Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, with a score of 5 indicating a similar timbre between CI and NH.
6 months post-activation
Perception of timbre
Time Frame: 12 months post-activation
Score on Visual Analog Scale (VAS). Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, with a score of 5 indicating a similar timbre between CI and NH.
12 months post-activation
Localization
Time Frame: 3 months post-activation
Root mean square localization error (RMSE) in degrees
3 months post-activation
Localization
Time Frame: 6 months post-activation
Root mean square localization error (RMSE) in degrees
6 months post-activation
Localization
Time Frame: 12 months post-activation
Root mean square localization error (RMSE) in degrees
12 months post-activation
Melodic interval perception
Time Frame: 3 months post-activation
Psychometric function of melodic intervals
3 months post-activation
Melodic interval perception
Time Frame: 6 months post-activation
Psychometric function of melodic intervals
6 months post-activation
Melodic interval perception
Time Frame: 12 months post-activation
Psychometric function of melodic intervals
12 months post-activation
Sound quality
Time Frame: 3 months post-activation
Sound quality ratings of four groups of piano samples ranging from consonant (group A) to most dissonant (group D)
3 months post-activation
Sound quality
Time Frame: 6 months post-activation
Sound quality ratings of four groups of piano samples ranging from consonant (group A) to most dissonant (group D)
6 months post-activation
Sound quality
Time Frame: 12 months post-activation
Sound quality ratings of four groups of piano samples ranging from consonant (group A) to most dissonant (group D)
12 months post-activation
Music and cochlear implant questionnaire (MCIQ)
Time Frame: 3 months post-activation
Qualitative interpretation of questionnaire subdomains: motivation to listen to music, musical behavior, musical preferences, music perception abilities, sound quality perception, musical background and music rehabilitation.
3 months post-activation
Music and cochlear implant questionnaire (MCIQ)
Time Frame: 6 months post-activation
Qualitative interpretation of questionnaire subdomains: motivation to listen to music, musical behavior, musical preferences, music perception abilities, sound quality perception, musical background and music rehabilitation.
6 months post-activation
Music and cochlear implant questionnaire (MCIQ)
Time Frame: 12 months post-activation
Qualitative interpretation of questionnaire subdomains: motivation to listen to music, musical behavior, musical preferences, music perception abilities, sound quality perception, musical background and music rehabilitation.
12 months post-activation
HISQUI19 questionnaire
Time Frame: 3 months post-activation
Total score and classification of self-perceived auditory benefit. The 19 items are rated on a 7-point Likert scale ranging from always (99%) to never (1%). To calculate the overall score the corresponding numerical value of each item (from always = 7 to never = 1) is added. Uncompleted items and the response option "not applicable" correspond to 0 in this calculation. A total score of less than 30, 30-59, 60-89, 90-109, and 110-133 is respectively classified as a very poor, poor, moderate, good, and very good self-perceived auditory benefit.
3 months post-activation
HISQUI19 questionnaire
Time Frame: 6 months post-activation
Total score and classification of self-perceived auditory benefit. The 19 items are rated on a 7-point Likert scale ranging from always (99%) to never (1%). To calculate the overall score the corresponding numerical value of each item (from always = 7 to never = 1) is added. Uncompleted items and the response option "not applicable" correspond to 0 in this calculation. A total score of less than 30, 30-59, 60-89, 90-109, and 110-133 is respectively classified as a very poor, poor, moderate, good, and very good self-perceived auditory benefit.
6 months post-activation
HISQUI19 questionnaire
Time Frame: 12 months post-activation
Total score and classification of self-perceived auditory benefit. The 19 items are rated on a 7-point Likert scale ranging from always (99%) to never (1%). To calculate the overall score the corresponding numerical value of each item (from always = 7 to never = 1) is added. Uncompleted items and the response option "not applicable" correspond to 0 in this calculation. A total score of less than 30, 30-59, 60-89, 90-109, and 110-133 is respectively classified as a very poor, poor, moderate, good, and very good self-perceived auditory benefit.
12 months post-activation
Speech, Spatial and Qualities of Hearing scale (SSQ12)
Time Frame: 3 months post-activation
Total score and score in the speech, spatial and quality domain. The 12 items of this questionnaire are rated on a visual analog scale from 0 to 10 and the overall score is calculated by taking the average of the scores of these 12 items. For the overall score and the score on each subdomain, the score ranges between 0-10 and a higher score indicates a better outcome.
3 months post-activation
Speech, Spatial and Qualities of Hearing scale (SSQ12)
Time Frame: 6 months post-activation
Total score and score in the speech, spatial and quality domain. The 12 items of this questionnaire are rated on a visual analog scale from 0 to 10 and the overall score is calculated by taking the average of the scores of these 12 items. For the overall score and the score on each subdomain, the score ranges between 0-10 and a higher score indicates a better outcome.
6 months post-activation
Speech, Spatial and Qualities of Hearing scale (SSQ12)
Time Frame: 12 months post-activation
Total score and score in the speech, spatial and quality domain. The 12 items of this questionnaire are rated on a visual analog scale from 0 to 10 and the overall score is calculated by taking the average of the scores of these 12 items. For the overall score and the score on each subdomain, the score ranges between 0-10 and a higher score indicates a better outcome.
12 months post-activation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Griet Mertens, Prof., University Hospital, Antwerp

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

July 9, 2026

First Submitted That Met QC Criteria

July 9, 2026

First Posted (Actual)

July 14, 2026

Study Record Updates

Last Update Posted (Actual)

July 21, 2026

Last Update Submitted That Met QC Criteria

July 17, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe